Arana A, Varas C, Gonzalez-Perez A, Gutierrez L, Bjerrum L, Garcia Rodriguez LA. Hormonal therapy and cerebrovascular events: a population-based nested case-control study. Menopause. 2006 Sep 1;13(5):730-6.
Sanchez Matienzo D, Lanza LL, McQuay L, Gutierrez L, Arana Navarro A, Perez-Gutthann S. Descriptive study of users of depo-medroxyprogesterone acetate (DMPA) in the mhra gprd. Presented at the 22nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 27, 2006. Lisbon, Portugal.
Arellano FM, Wentworth CE, Arana A. Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis. Presented at the 22nd International Conference on Pharmacoepidemiology; August 2006. Lisbon, Portugal.
Sanchez-Matienzo D, Arana A, Castellsague J, Perez-Gutthann S. Hepatic disorders in patients treated with COX-2 selective inhibitors or nonselective NSAIDs: a case/noncase analysis of spontaneous reports. Clin Ther. 2006 Aug 1;28(8):1123-32.
Sanchez-Matienzo D, Arana A, Castellsague J, Perez-Gutthann S. Hepatic disorders in users of NSAIDs, including COX-2 selective inhibitors. A case/non-case analysis of spontaneous reports. Clin Ther. 2006;28(8):1123-32.
Arana A, Castellsague J, Tognoni G, Perez-Gutthann S. Individual daily questionnaires in pharmacoepidemiologic studies and ways of analyzing recurrent events. Comparing tolerability of Desferal® in a real-life setting. Presented at the 13th International Conference on Pharmacoepidemiology; 1997. Orlando, FL. [abstract] Pharmacoepidemiol Drug Saf. 1997 Aug; 6(S2).
Arboretti R, Marachetti F, Carinci F, Alberti D, Arana A, Tognoni G. Evaluation of care and life of patients with beta-thalassaemia major. Presented at the 6th International Conference on Thalassaemia and the Heamoglobinopathies; 1997. Malta.